ATE343570T1 - Neue verbindung, 2-amino-3-(2-(aplpha- mannopyranosyl) indol-3-yl) propionsäure, verfahren zur herstellung und methoden zur in vivo untersuchung mit der neuen verbindung - Google Patents
Neue verbindung, 2-amino-3-(2-(aplpha- mannopyranosyl) indol-3-yl) propionsäure, verfahren zur herstellung und methoden zur in vivo untersuchung mit der neuen verbindungInfo
- Publication number
- ATE343570T1 ATE343570T1 AT98938893T AT98938893T ATE343570T1 AT E343570 T1 ATE343570 T1 AT E343570T1 AT 98938893 T AT98938893 T AT 98938893T AT 98938893 T AT98938893 T AT 98938893T AT E343570 T1 ATE343570 T1 AT E343570T1
- Authority
- AT
- Austria
- Prior art keywords
- mannopyranosyl
- indol
- amino
- new compound
- ylüpropionic
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 title 2
- -1 INDOL-3-YL Chemical class 0.000 title 1
- 235000019260 propionic acid Nutrition 0.000 title 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 6
- 210000004408 hybridoma Anatomy 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22406597 | 1997-08-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE343570T1 true ATE343570T1 (de) | 2006-11-15 |
Family
ID=16808027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98938893T ATE343570T1 (de) | 1997-08-20 | 1998-08-19 | Neue verbindung, 2-amino-3-(2-(aplpha- mannopyranosyl) indol-3-yl) propionsäure, verfahren zur herstellung und methoden zur in vivo untersuchung mit der neuen verbindung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6610502B1 (de) |
| EP (1) | EP1016866B1 (de) |
| JP (1) | JP4180790B2 (de) |
| AT (1) | ATE343570T1 (de) |
| AU (1) | AU8747198A (de) |
| CA (1) | CA2300913C (de) |
| DE (1) | DE69836279T2 (de) |
| WO (1) | WO1999009411A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004105753A1 (ja) * | 2003-05-29 | 2004-12-09 | Kyowa Medex Co., Ltd. | 抗うつ剤または抗うつ用飲食品 |
| CA2635531C (en) | 2005-12-29 | 2014-06-17 | Lexicon Pharmaceutical Inc. | Multicyclic amino acid derivatives and methods of their use |
| WO2014046163A1 (ja) * | 2012-09-20 | 2014-03-27 | 協和メデックス株式会社 | 検体中の２－アミノ－３－［２－（α－マンノピラノシル）インドール－３－イル］プロピオン酸の測定方法 |
| JP7272627B2 (ja) * | 2019-01-24 | 2023-05-12 | 公立大学法人和歌山県立医科大学 | 卵巣腫瘍の評価用バイオマーカー |
| CN111217793B (zh) * | 2020-01-17 | 2023-03-31 | 南开大学 | 一种C-α-甘露糖基化色氨酸中间体及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3394280B2 (ja) | 1993-01-25 | 2003-04-07 | 協和醗酵工業株式会社 | 親水性β−カルボリン酸誘導体 |
| US5602038A (en) | 1994-07-25 | 1997-02-11 | Private Clinic Laboratories, Inc. | Method of determining renal clearances |
| JPH08283179A (ja) | 1995-04-07 | 1996-10-29 | Kureha Chem Ind Co Ltd | クリアランス測定用標準曲線及びクリアランス測定方法 |
-
1998
- 1998-08-19 AT AT98938893T patent/ATE343570T1/de not_active IP Right Cessation
- 1998-08-19 JP JP2000510024A patent/JP4180790B2/ja not_active Expired - Fee Related
- 1998-08-19 AU AU87471/98A patent/AU8747198A/en not_active Abandoned
- 1998-08-19 EP EP98938893A patent/EP1016866B1/de not_active Expired - Lifetime
- 1998-08-19 CA CA002300913A patent/CA2300913C/en not_active Expired - Fee Related
- 1998-08-19 US US09/486,115 patent/US6610502B1/en not_active Expired - Lifetime
- 1998-08-19 DE DE69836279T patent/DE69836279T2/de not_active Expired - Lifetime
- 1998-08-19 WO PCT/JP1998/003671 patent/WO1999009411A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69836279D1 (de) | 2006-12-07 |
| AU8747198A (en) | 1999-03-08 |
| CA2300913A1 (en) | 1999-02-25 |
| EP1016866B1 (de) | 2006-10-25 |
| CA2300913C (en) | 2007-06-12 |
| DE69836279T2 (de) | 2007-05-31 |
| US6610502B1 (en) | 2003-08-26 |
| EP1016866A1 (de) | 2000-07-05 |
| JP4180790B2 (ja) | 2008-11-12 |
| WO1999009411A1 (fr) | 1999-02-25 |
| EP1016866A4 (de) | 2002-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE145007T1 (de) | Verfahren zur herstellung monoklonaler antikörper mit hilfe eines keimfreien tieres | |
| EP0868881A4 (de) | Vorrichtung und verfahren zur einstellung von randbedingungen und instrumentzummessen von biologischen grössen | |
| DE69733560D1 (de) | TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP | |
| DK0943097T3 (da) | Fremgangsmåde til at påvise IgE | |
| ATE230487T1 (de) | Verfahren zur frühen diagnose von carcinomen | |
| DE60234759D1 (de) | Nachweisverfahren für eine frühe nierenkrankheit in tieren | |
| DE602005022924D1 (de) | Verfahren zur diagnose von morbus crohn | |
| ATE395812T1 (de) | Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests | |
| ATE343570T1 (de) | Neue verbindung, 2-amino-3-(2-(aplpha- mannopyranosyl) indol-3-yl) propionsäure, verfahren zur herstellung und methoden zur in vivo untersuchung mit der neuen verbindung | |
| JPH0543600A (ja) | 抗体または抗原固定化絹フイブロイン膜および免疫測定用センサー | |
| EP0685070A1 (de) | Acylierte proteinaggregate und deren verwendung zur entstörung von immunoassays | |
| FI85946C (fi) | Foerfarande foer framstaellning av en bispecifik antikropp och bestaemningsfoerfarande varvid denna anvaends. | |
| DE60207016D1 (de) | Verfahren und Kit zur Quantifizierung von Beta-Laktam Penizillinen | |
| ATE397659T1 (de) | Polyklonale antikörper gegen den menschlichen alpha-pdgf-rezeptor und dessen verwendung | |
| DE602004020372D1 (de) | Verfahren zur probenvorbehandlung sowie immunologisches testverfahren unter verwendung davon | |
| DE60035267D1 (de) | Verfahren zur analyse der menge an intraabdominalem fettgewebe | |
| DE69132091D1 (de) | Verfahren zur Herstellung von Indolderivaten | |
| WO2005010533A3 (en) | Methods and kits for the detection of prion diseases | |
| DE69837539D1 (de) | Löslicher laminin rezeptor vorläufer und verfahren zur verhinderung von laminins interaktionen | |
| ATE78342T1 (de) | Verfahren zur feststellung von schwangerschaftsstoerungen. | |
| EP1780215A4 (de) | Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn | |
| SE9602234D0 (sv) | A novel diagnostic method utilizing ECP, and reagents to be used in the methods | |
| DK0994353T3 (da) | Forbedret fremgangsmåde til allergidiagnostik | |
| ATE17049T1 (de) | Verfahren zur antigen-bestimmung. | |
| ATE256704T1 (de) | Antikörper und diagnostizierverfahren zur pestivirusdiagnose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |